Robert A. Hegele

发表

Human Smooth Muscle Cell Subpopulations Differentially Accumulate Cholesteryl Ester When Exposed to Native and Oxidized Lipoproteins

C. Argmann, R. Hegele, J. Pickering, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Regulation of Macrophage Cholesterol Efflux through Hydroxymethylglutaryl-CoA Reductase Inhibition

C. Argmann, R. Hegele, J. Pickering, 2005, Journal of Biological Chemistry.

RECENT HIGHLIGHTS OF ATVB

C. Weber, Y. Döring, E. V. D. Vorst, 2019 .

Common Low-Density Lipoprotein Receptor p.G116S Variant Has a Large Effect on Plasma Low-Density Lipoprotein Cholesterol in Circumpolar Inuit Populations

R. Hegele, P. Bjerregaard, A. McIntyre, 2015, Circulation. Cardiovascular genetics.

Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans.

E. Rimm, Mingyao Li, M. Reilly, 2009, The Journal of clinical investigation.

Transforming Growth Factor-β1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants

C. Sawyez, J. Y. Edwards, Carmen A. Argmann, 2001 .

Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma.

C. Argmann, R. Hegele, M. Huff, 1999, Journal of lipid research.

Apolipoprotein A-I deficiency. Biochemical and metabolic characteristics.

R. Hegele, A. Kuksis, T. Wolever, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins.

B. Zinman, F. Sun, S. Harris, 1997, Arteriosclerosis, thrombosis, and vascular biology.

@Western Scholarship@Western

B. Leake, Sara E. Mansell, W. Teft, 2022 .

Successful outcome in severe pregnancy-associated hyperlipemia: a case report and literature review.

R. Hegele, P. Connelly, S. Hsia, 1995, The American journal of the medical sciences.

Applying Atherosclerotic Risk Prevention Guidelines to Elderly Patients: A Bridge Too Far?

R. Hegele, K. Rockwood, S. Harris, 2016, The Canadian journal of cardiology.

Genetic variation on chromosome 1 associated with variation in body fat distribution in men.

R. Hegele, P. Connelly, J. Brunt, 1995, Circulation.

A consensus statement from the European Atherosclerosis Society Consensus Panel

B. Sluis, A. Catapano, B. Ference, 2018 .

Low-density lipoproteins cause atherosclerotic cardiovascular disease.1. Evidence from genetic, epidemiologic, and clinical studies

B. Sluis, A. Catapano, B. Ference, 2018 .

Evidence from A from

B. Sluis, A. Catapano, B. Ference, 2017 .

Relationship of the metabolic syndrome to carotid ultrasound traits

B. Zinman, A. Fenster, R. Hegele, 2006, Cardiovascular ultrasound.

Editorial : Phenomics , Lamin A / C , and Metabolic Disease

R. Hegele, Robert A. Hegele, 2007 .

Genetic prediction of coronary heart disease: lessons from Canada.

R. Hegele, Robert A. Hegele, 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly[S]

A. D. de Craen, R. Hegele, R. Westendorp, 2010, Journal of Lipid Research.

Review the Polygenic Nature of Hypertriglyceridaemia: Implications for Defi Nition, Diagnosis, and Management

J. Borén, S. Humphries, M. Taskinen, 2022 .

[Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society].

P. Pajukanta, A. Tybjaerg-hansen, J. Kuivenhoven, 2015, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

A hepatic lipase gene mutation associated with heritable lipolytic deficiency.

R. Hegele, J. Little, P. Connelly, 1991, The Journal of clinical endocrinology and metabolism.

Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians.

B. Zinman, R. Hegele, A. Hanley, 1997, Hypertension.

Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660)

R. Hegele, H. Cao, S. Rabkin, 2007, Clinical genetics.

Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome.

R. Hegele, Robert A. Hegele, 2000, Molecular genetics and metabolism.

Blood pressure among the Inuit (Eskimo) populations in the Arctic

T. K. Young, R. Hegele, P. Bjerregaard, 2003, Scandinavian journal of public health.

Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites.

R. Hegele, P. Connelly, J. Brunt, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus.

B. Zinman, R. Hegele, A. Hanley, 2004, The Journal of clinical endocrinology and metabolism.

Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.

B. Zinman, R. Hegele, H. Cao, 2000, Diabetes care.

Lessons from genetic studies in native Canadian populations.

R. Hegele, Robert A. Hegele, 2009, Nutrition reviews.

Genetic prediction of atherosclerosis: lessons from studies in native Canadian populations.

R. Hegele, Robert A. Hegele, 1999, Clinica chimica acta; international journal of clinical chemistry.

Variation in the AU(AT)-rich element within the 3'-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians.

S. Scherer, L. Tsui, B. Zinman, 1998, The Journal of clinical endocrinology and metabolism.

Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations.

B. Zinman, R. Hegele, A. Hanley, 1999, Atherosclerosis.